Colombo Giorgia, Gelardi Edoardo Luigi Maria, Balestrero Federica Carolina, Moro Marianna, Travelli Cristina, Genazzani Armando A
Department of Pharmaceutical Sciences, Università Del Piemonte Orientale, Novara, Italy.
Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Front Pharmacol. 2021 Nov 22;12:758320. doi: 10.3389/fphar.2021.758320. eCollection 2021.
Tumour cells modify their cellular metabolism with the aim to sustain uncontrolled proliferation. cells necessitate adequate amounts of NAD and NADPH to support several enzymes that are usually overexpressed and/or overactivated. Nicotinamide adenine dinucleotide (NAD) is an essential cofactor and substrate of several NAD-consuming enzymes, such as PARPs and sirtuins, while NADPH is important in the regulation of the redox status in cells. The present review explores the rationale for targeting the key enzymes that maintain the cellular NAD/NADPH pool in colorectal cancer and the enzymes that consume or use NADP(H).
肿瘤细胞会改变其细胞代谢,以维持不受控制的增殖。细胞需要足够量的烟酰胺腺嘌呤二核苷酸(NAD)和还原型辅酶II(NADPH)来支持几种通常过度表达和/或过度激活的酶。烟酰胺腺嘌呤二核苷酸(NAD)是几种消耗NAD的酶(如聚(ADP-核糖)聚合酶(PARP)和沉默调节蛋白)的必需辅助因子和底物,而NADPH在调节细胞氧化还原状态方面很重要。本综述探讨了靶向维持结直肠癌中细胞NAD/NADPH库的关键酶以及消耗或利用NADP(H)的酶的理论依据。